Search Count: 55
 |
Hiv-1 Wild Type Protease With Grl-072-17A, A Substituted Tetrahydrofuran Derivative Based On Darunavir As P2 Group
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.32 Å Release Date: 2024-07-24 Classification: VIRAL PROTEIN |
 |
Hiv-1 Reverse Transcriptase Mutant Q151M/Y115F/F116Y:Dna:E-Cfcp-Tp Ternary Complex
Organism: Human immunodeficiency virus 1, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.62 Å Release Date: 2024-07-17 Classification: TRANSFERASE Ligands: GOL, MG, XTE |
 |
Hiv-1 Reverse Transcriptase Mutant Q151M/Y115F/F116Y/L74V:Dna:E-Cfcp-Tp Ternary Complex
Organism: Human immunodeficiency virus 1, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.70 Å Release Date: 2024-07-17 Classification: TRANSFERASE Ligands: XTE, GOL, MG |
 |
Hiv-1 Reverse Transcriptase Mutant Q151M/Y115F/F116Y/L74V:Dna:Etv-Tp Ternary Complex
Organism: Human immunodeficiency virus 1, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.33 Å Release Date: 2024-07-17 Classification: TRANSFERASE Ligands: ET9, MG, GOL |
 |
Hiv-1 Reverse Transcriptase Mutant Q151M/Y115F/F116Y/L74V:Dna:Dgtp Ternary Complex
Organism: Human immunodeficiency virus 1, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.31 Å Release Date: 2024-07-17 Classification: TRANSFERASE Ligands: DGT, MG, GOL |
 |
Crystal Structure Of Sars-Cov-2 Main Protease (Authentic Protein) In Complex With An Inhibitor Tkb-245
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2024-04-24 Classification: VIRAL PROTEIN, HYDROLASE/INHIBITOR Ligands: T2L |
 |
Crystal Structure Of Sars-Cov-2 Main Protease E166V Mutant In Complex With An Inhibitor Tkb-245
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2024-04-24 Classification: VIRAL PROTEIN, HYDROLASE/INHIBITOR Ligands: T2L |
 |
Crystal Structure Of Sars-Cov-2 Main Protease A191T Mutant In Complex With An Inhibitor 5H
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.49 Å Release Date: 2024-04-24 Classification: VIRAL PROTEIN, HYDROLASE/INHIBITOR Ligands: V7G |
 |
Crystal Structure Of Sars-Cov-2 Main Protease A191T Mutant In Complex With An Inhibitor Nirmatrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.58 Å Release Date: 2024-04-24 Classification: VIRAL PROTEIN, HYDROLASE/INHIBITOR Ligands: 4WI, PEG |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2024-01-24 Classification: VIRAL PROTEIN |
 |
Crystal Structure Of Sars-Cov-2 Main Protease E166V Mutant In Complex With An Inhibitor Tkb-272
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.07 Å Release Date: 2023-12-20 Classification: VIRAL PROTEIN Ligands: WOK, PEG |
 |
Crystal Structure Of Sars-Cov-2 Main Protease In Complex With An Inhibitor Tkb-272
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.74 Å Release Date: 2023-12-13 Classification: VIRAL PROTEIN Ligands: WOK, PEG |
 |
Hiv-1 Wild Type Protease With Grl-02519A, With N-(2,5-Dimethylphenyl)-4-(Pyridin-3-Yl)Pyrimidin-2-Amine As P2-P3 Group
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.25 Å Release Date: 2023-05-24 Classification: HYDROLASE/INHIBITOR Ligands: Y9R, NA, CL, ACT, GOL, FMT |
 |
Hiv-1 Wild Type Protease With Grl-03419A, With N-(2,5-Dimethylphenyl)-4-(Pyridin-3-Yl)Pyrimidin-2-Amine As P2-P3 Group And 3,5-Difluorophenylmethyl As The P1 Group
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.12 Å Release Date: 2023-05-24 Classification: HYDROLASE/INHIBITOR |
 |
Hiv-1 Integrase Catalytic Core Domain Mutant (Kgd) In Complex With Inhibitor Grl-142
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:3.00 Å Release Date: 2023-03-22 Classification: VIRAL PROTEIN Ligands: 7OA, SO4 |
 |
Crystal Structure Of Sars-Cov-2 Main Protease In Complex With An Inhibitor Tkb-245
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.46 Å Release Date: 2022-09-21 Classification: HYDROLASE/INHIBITOR Ligands: T2L, DMS |
 |
Crystal Structure Of Sars-Cov-2 Main Protease In Complex With An Inhibitor Tkb-198
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.59 Å Release Date: 2022-08-24 Classification: HYDROLASE/INHIBITOR Ligands: 1PE, MES, DMS, PG0, T1X |
 |
Crystal Structure Of Sars-Cov-2 Main Protease In Complex With Inhibitor Tkb-248
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2022-08-24 Classification: HYDROLASE/INHIBITOR Ligands: T43, DMS, ZN |
 |
Hiv-1 Wild Type Protease With Grl-05816A, With C-4 Substituted Cyclohexane-Fused Bis-Tetrahydrofuran (Chf-Thf) Derivatives As P2-Ligand [Diastereomer 1]
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.13 Å Release Date: 2022-03-02 Classification: ANTIVIRAL PROTEIN/INHIBITOR |
 |
Hiv-1 Wild Type Protease With Grl-01717A, With C-4 Substituted Cyclohexane-Fused Bis-Tetrahydrofuran (Chf-Thf) Derivatives As P2-Ligand [Diastereomer 2]
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.21 Å Release Date: 2022-03-02 Classification: VIRAL PROTEIN/INHIBITOR |